The distinction between fat and muscle loss is becoming one of the most consequential health questions for the millions now on GLP-1 treatments.

DEXA body composition scanning has become the gold standard for answering it. In a few minutes, you get a precise breakdown of fat mass, visceral fat, lean mass, and bone density — the data that tells you whether your GLP-1 treatment is doing what it’s supposed to do. A clinical-grade snapshot of your body composition over time.

The key word is over time. DEXA’s real power is longitudinal: scanning every 3-6 months to track whether you’re preserving muscle while losing fat. That’s the data that changes treatment decisions.

But longitudinal data is only meaningful for your GLP-1 treatment if it produces rigorous, clinical-grade tracking.

As low-cost DEXA services expand across the longevity and medical weight loss market, Fitnescity Health established the Clinical Integrity Standard — a quality framework to educate consumers and elevate the industry.

Unlike DEXA bone density testing — which carries diagnostic, billing, and malpractice accountability — DEXA body composition operates without equivalent consequential quality requirements.

The Clinical Integrity Standard’s goal is to identify and vet DEXA operators committed to conditions that make longitudinal DEXA data more trustworthy. It establishes three pillars:

1. Fixed-site, stationary test centers. Fitnescity Health’s network includes world-class hospital systems, renowned radiology networks, and carefully-vetted wellness facilities. This fixed-site model is purpose-built to facilitate adherence to the same-machine recommendation from the International Society for Clinical Densitometry (ISCD) — ensuring that changes in an individual’s data reflect true physiological shifts, not environmental drift.
2. Longitudinal quality assurance. Operators should maintain calibration protocols, technologist training, and reporting consistency per ISCD guidance.
3. Credentialed oversight. Results should be reviewed and contextualized by a credentialed professional capable of interpreting findings and guiding next steps.

Because when DEXA informs a GLP-1 treatment decision, the data deserves to be reliable. The lowest-cost option may not always deliver the reproducible longitudinal data these decisions require.

The GLP-1 revolution is one of the most significant shifts in metabolic medicine in a generation. DEXA is the tool that makes it measurable, turning a weight loss journey into a precision health intervention with data that actually guides treatment.

Fitnescity Health’s network of 1,000+ fixed-site locations nationwide integrates with platforms building the future of GLP-1 care, longevity medicine, and metabolic health. If you’re building that platform, let’s talk.

Learn more at fitnescity.com/cis or reach out directly.

Disclaimer: The Clinical Integrity Standard (CIS) is a private, voluntary quality framework developed by Fitnescity Health. It is not a government, regulatory, or FDA-sponsored certification. Fitnescity Health is a sponsor of the ISCD. The CIS is not affiliated with, endorsed by, or developed in partnership with the ISCD. The ISCD has not reviewed, approved, certified, or endorsed the CIS. The CIS and Fitnescity Health’s DEXA scans are for informational purposes only and do not constitute medical advice, diagnosis, or treatment. Individuals should consult their prescribing physician regarding GLP-1 therapies, sarcopenia, or any other medical conditions.